Instead of working through antibody - mediated immunity, Liang says successful
prophylactic vaccines against the virus might have to work through cell - mediated immunity, which means immune cells are taught to attack infected cells.
The focus of this application is to develop an adenovirus - based
vaccine against rabies
virus that can provide rapid immunity following a single administration to achieve
prophylactic status and as well as in response to a bioterrorism attack.
Using enhanced DNA technology, the lab has designed DNA
vaccines that drive immune responses in
prophylactic or therapeutic settings
against Human Immunodeficiency
Virus (HIV), Dengue (DV), Chikungunya virus (CHIKV), Middle Eastern Respiratory Syndrome (MERS) virus, and Zika Virus
Virus (HIV), Dengue (DV), Chikungunya
virus (CHIKV), Middle Eastern Respiratory Syndrome (MERS) virus, and Zika Virus
virus (CHIKV), Middle Eastern Respiratory Syndrome (MERS)
virus, and Zika Virus
virus, and Zika
Virus Virus (ZV).